Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
591.50
Change Change %
21.35 3.74%

Updated:07 May, 2021, 15:59 PM IST

BSE
591.80
Change Change %
21.85 3.83%

Updated:07 May, 2021, 16:00 PM IST

Glenmark Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18 MAR'17
Operational & Financial Ratios:
   Earnings Per Share (Rs) 35.95 75.86
   DPS(Rs) 2.00 2.00
   Book NAV/Share(Rs) 367.90 334.38
Margin Ratios:
   Yield on Advances 0.00 0.00
   Yield on Investments 0.00 0.00
   Cost of Liabilities 0.00 0.00
   NIM 0.00 0.00
   Interest Spread 0.00 0.00
Performance Ratios:
   ROA(%) 6.32 16.27
   ROE(%) 10.24 25.48
   ROCE(%) 11.02 26.57
Efficiency Ratios:
   Cost Income Ratio 0.00 0.00
   Core Cost Income Ratio 0.00 0.00
   Operating Costs to Assets 0.00 0.00
Capitalisation Ratios:
   Tier 1 ratio 0.00 0.00
   Tier 2 ratio 0.00 0.00
   CAR 0.00 0.00
Valuation Parameters:
   PER(x) 14.66 11.31
   PCE(x) 13.13 10.78
   Price / Book(x) 1.43 2.57
   Yield(%) 0.38 0.23
   EV / Net Sales(x) 2.76 3.35
   EV / Core EBITDA(x) 11.57 8.77
   EV / EBIT(x) 12.54 9.88
   EV / CE(x) 1.05 1.74
   M Cap / Sales 2.32 3.03
Growth Ratio:
   Core Operating Income Growth 25.10 321.27
   Operating Profit Growth -49.85 61.85
   Net Profit Growth -52.61 44.22
   BVPS Growth 10.02 28.11
   Advances Growth 0.00 0.00
   EPS Growth(%) -52.61 44.21
Liquidity Ratios:
   Loans / Deposits(x) 0.00 0.00
   Total Debt / Equity(x) 0.00 0.00
   Current Ratio(x) 0.00 0.00
   Quick Ratio(x) 0.00 0.00
   Total Debt / Mcap(x) 0.00 0.00
   Net NPA in Rs. Million 0.00 0.00
Top
Listen to the latest songs, only on JioSaavn.com